How big is Simulations Plus, Inc.?

As of Jun 18, Simulations Plus, Inc. has a market capitalization of 368.43 million, with net sales of 78.55 million and a net profit of 7.26 million over the latest four quarters. The balance sheet as of Aug 24 shows shareholder's funds of 182.43 million and total assets of 207.64 million.

As of Jun 18, Simulations Plus, Inc. has a market capitalization of 368.43 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 78.55 million and a net profit of 7.26 million for the latest four quarters.<BR><BR>As of Aug 24, the balance sheet shows shareholder's funds of 182.43 million and total assets of 207.64 million.

What does Simulations Plus, Inc. do?

Simulations Plus, Inc. develops software for drug discovery and development, with recent net sales of $22 million and a net profit of $3 million. The company has a market cap of $368.43 million and key metrics include a P/E ratio of 107.00 and a dividend yield of 0.32%.

Overview:<BR>Simulations Plus, Inc. is a developer of drug discovery and development software, operating within the Software Products industry and classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>- Most recent Net Sales: 22 Million (Quarterly Results - Feb 2025)<BR>- Most recent Net Profit: 3 Million (Quarterly Results - Feb 2025)<BR>- Market-cap: USD 368.43 Million (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 107.00<BR>- Dividend Yield: 0.32%<BR>- Debt Equity: -0.11<BR>- Return on Equity: 2.74%<BR>- Price to Book: 1.94<BR><BR>Contact Details:<BR>- Address: 42505 10th St W, LANCASTER CA: 93534-7059<BR>- Tel: 1 661 7237723<BR>- Fax: 1 661 7235524<BR>- Website: https://www.simulations-plus.com/

Should I buy, sell or hold Simulations Plus, Inc.?

Who are in the management team of Simulations Plus, Inc.?

As of March 2022, the management team of Simulations Plus, Inc. includes Chairman Walter Woltosz and independent directors Dr. Lisa LaVange, Dr. John Paglia, Dr. David Ralph, and Dr. Daniel Weiner.

As of March 2022, the management team of Simulations Plus, Inc. includes Mr. Walter Woltosz, who serves as the Chairman of the Board. Additionally, the board features several independent directors: Dr. Lisa LaVange, Dr. John Paglia, Dr. David Ralph, and Dr. Daniel Weiner.

Is Simulations Plus, Inc. overvalued or undervalued?

As of July 14, 2025, Simulations Plus, Inc. is considered risky and overvalued, with a high P/E ratio of 107 and poor stock performance, reflected in a year-to-date return of -43.13%, compared to the S&P 500's 12.22%.

As of 14 July 2025, the valuation grade for Simulations Plus, Inc. has moved from very expensive to risky, indicating a shift in perception regarding its market value. The company appears to be overvalued, as evidenced by a P/E ratio of 107, which significantly exceeds the peer average, and an EV to EBITDA ratio of 44.51, suggesting that investors are paying a premium for earnings before interest, taxes, depreciation, and amortization. Additionally, the Price to Book Value stands at 2.92, further highlighting the disparity between the company's market price and its book value.<BR><BR>In comparison to its peers, Simulations Plus, Inc. has a P/E ratio of 22.90, while Everbridge, Inc. shows a negative P/E of -28.60, and Definitive Healthcare Corp. has a P/E of 8.68, indicating that Simulations Plus is trading at a higher valuation despite its underperformance. The company's recent stock performance has been poor, with a year-to-date return of -43.13%, significantly lagging behind the S&P 500's return of 12.22% in the same period, which reinforces the notion of overvaluation.

Is Simulations Plus, Inc. technically bullish or bearish?

As of September 11, 2025, Simulations Plus, Inc. shows a mildly bearish trend influenced by daily moving averages and KST, despite a mildly bullish weekly MACD, while significantly underperforming the S&P 500 with a year-to-date return of -43.13%.

As of 11 September 2025, the technical trend for Simulations Plus, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages and the KST, which are both bearish. The weekly MACD indicates a mildly bullish signal, but this is offset by the monthly bearish indicators in MACD, Bollinger Bands, and KST. The Dow Theory shows a mildly bullish stance on the weekly timeframe but remains bearish monthly. <BR><BR>In terms of performance, the stock has underperformed significantly compared to the S&P 500, with a year-to-date return of -43.13% versus the S&P 500's 12.22%, and a one-year return of -49.57% compared to the S&P 500's 17.14%.